Search - tctmd.com

Displaying 641 - 660 of 807

Sort: Relevancy | Date

News Industry News

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

December 16, 2013

News Industry News

Boston Scientific and The Medicines Company Announce U.S. Co-Promotion Agreement for Promus PREMIER™ Stent System

December 05, 2013

News Industry News

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

November 24, 2013

News Industry News

Removing Blood Clots during PCI Does Not Improve Outcomes Compared To Standard Angioplasty in Patients with Non-St-Elevation Myocardial Infarction

October 31, 2013

News Industry News

New Study Evaluates Outcomes of Providing Access to Platelet Function Testing in a Clinical Setting

October 31, 2013

News Industry News

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

October 31, 2013

News Industry News

Therapeutic Hypothermia Is Safe and Feasible As Adjunctive Care for Heart Attack Patients

October 30, 2013

News Industry News

Study Find Pre-Hospital Administration of Bivalirudin Substantially Improves Outcomes Compared to Heparin in Heart Attack Patients

October 30, 2013

News Industry News

STENTYS Self-Apposing Stent Performs Well in New Coronary Indications

October 30, 2013

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

October 29, 2013

News Industry News

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

October 29, 2013

News Industry News

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

October 29, 2013

News Industry News

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

October 28, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

News Industry News

Juventas Therapeutics completes enrollment of Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure

October 28, 2013

News Daily News

System-Wide Effort Produces Lasting Improvement in D2B Times for STEMI Transfers

Caitlin E. Cox

September 27, 2013

News Daily News

Better Door-to-Balloon Times Do Not Translate to Lower Mortality in STEMI Patients

Jason Kahn

September 05, 2013

News Industry News

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

September 03, 2013

News Industry News

Boston Scientific Completes Enrollment In SuperNOVA Trial Evaluating Innova™ Self-Expanding Stent System

August 19, 2013

News Daily News

Quitting Smoking After PCI Can Add Years to Patients’ Lives

L.A. McKeown

August 05, 2013

Advertisement

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

Boston Scientific and The Medicines Company Announce U.S. Co-Promotion Agreement for Promus PREMIER™ Stent System

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

Removing Blood Clots during PCI Does Not Improve Outcomes Compared To Standard Angioplasty in Patients with Non-St-Elevation Myocardial Infarction

New Study Evaluates Outcomes of Providing Access to Platelet Function Testing in a Clinical Setting

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

Therapeutic Hypothermia Is Safe and Feasible As Adjunctive Care for Heart Attack Patients

Study Find Pre-Hospital Administration of Bivalirudin Substantially Improves Outcomes Compared to Heparin in Heart Attack Patients

STENTYS Self-Apposing Stent Performs Well in New Coronary Indications

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Juventas Therapeutics completes enrollment of Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure

System-Wide Effort Produces Lasting Improvement in D2B Times for STEMI Transfers

Better Door-to-Balloon Times Do Not Translate to Lower Mortality in STEMI Patients

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

Boston Scientific Completes Enrollment In SuperNOVA Trial Evaluating Innova™ Self-Expanding Stent System

Quitting Smoking After PCI Can Add Years to Patients’ Lives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content